However, as digital health gains momentum, companies need to continually invest in security tools and services to detect (cybersecurity being one of the primary concerns) and keep risks in check.Nonetheless, given the rising medical awareness and economic prosperity, emerging economies have been witnessing solid demand for medical products and the momentum is anticipated to continue in the near term as well.It is important to mention here that with the coronavirus crisis intensifying since late February, elective procedures and other noncritical procedures have been impacted.You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.Zimmer Biomet Holdings, Inc. (ZBH): Zimmer Biomet is a leading musculoskeletal healthcare company that designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products.For this Warsaw, IN-based company, the estimated long-term earnings growth rate is at 6.9%.Price and Consensus: ZBH Stryker Corporation (SYK): Stryker is one of the world’s largest medical device companies operating in the global orthopedic market.